Overview
Title
To limit the impoundment, transfer, or reprogramming of Federal funds made available for the National Institutes of Health, and for other purposes.
ELI5 AI
H. R. 2855 is like a rule that says the money given to the National Institutes of Health (where they do important science to help keep people healthy) can't be moved around or used for other things unless a new rule is made that says it's okay. This way, the money meant for helping with health and research stays safe where it's supposed to be.
Summary AI
H. R. 2855 aims to safeguard funding for the National Institutes of Health by prohibiting the impoundment, transfer, or reprogramming of its funds unless new legislation explicitly authorizes such actions. The bill, introduced by Mr. Kennedy of New York and Ms. Williams of Georgia, requires the Secretary of Health and Human Services to certify annually that the funding rules are being followed, ensuring that money allocated for medical research is not redirected without clear legislative approval.
Published
Keywords AI
Sources
Bill Statistics
Size
Language
Complexity
AnalysisAI
General Summary of the Bill
House Bill 2855, introduced in the 119th Congress, aims to control how federal funds allocated to the National Institutes of Health (NIH) are managed. Under this proposed legislation, the funds that the NIH receives can no longer be impounded, transferred, or reprogrammed unless a new law is passed authorizing these actions. The bill is driven by an intent to safeguard medical research funding, thereby stabilizing financial support for NIH projects. It also mandates the Secretary of Health and Human Services to annually certify compliance with the Act's requirements to various congressional committees.
Summary of Significant Issues
A notable concern with this bill arises from its restrictive mandate on the handling of NIH funds. By disallowing any movement or alteration of funds without new statutory authority, the bill could limit flexibility in responding to emergencies or funding shifts required by urgent research demands. The requirement for new laws to permit such changes could introduce bureaucratic delays and administrative burdens.
Another issue is the ambiguity regarding the definition of "compliance." Without clear guidelines, there could be varied interpretations, affecting how different parties implement and enforce the Act.
The bill also outlines the need for reporting compliance to multiple congressional committees, which could lead to redundant and possibly burdensome administrative processes.
Impact on the Public
For the broader public, this bill might ensure a more consistent and predictable funding stream for medical research at the NIH, potentially resulting in steady progress in health research outcomes. This reliability could lead to advances in healthcare treatments and interventions that might directly benefit society.
On the downside, the inability to swiftly adapt funding to emerging public health crises could hinder timely research and response efforts, ultimately impacting public health preparedness and the development of rapid solutions for new or evolving health risks.
Impact on Specific Stakeholders
National Institutes of Health (NIH): The NIH might experience enhanced stability and predictability in its funding, which could facilitate long-term research planning. However, this restriction could also limit its agility in redirecting funds to where they might be most needed quickly.
Policymakers and Committees: The increased requirement for legislative action to authorize any significant financial shifts may add to the workload of lawmakers, who must now include specific references to this Act in new legislation. The multiple certification processes might also introduce additional administrative tasks.
Healthcare and Research Community: Researchers and healthcare professionals might benefit from the assurance of consistent funding, reducing concerns about financial interruptions influencing ongoing research projects. However, an inability to reallocate funds in response to pressing research needs could result in missed opportunities or delays in scientific progress.
In conclusion, while the "Protecting Medical Research Funding Act" aims to provide financial stability for the NIH, the potential inflexibility it introduces could hamper the ability to swiftly address new public health challenges. Balancing stability with adaptability will be crucial for maximizing the benefits of this legislation.
Issues
The restriction on the deferral, transfer, or reprogramming of NIH funds could limit the flexibility needed for adapting to unforeseen circumstances, potentially impacting urgent public health responses or innovative research initiatives. This issue is found in Section 2(a).
The requirement for specific statutory authority enacted into law, with an express reference to this Act, might cause bureaucratic delays, hindering timely financial decisions regarding NIH funding. This issue is noted in Section 2(a).
The Act does not define what constitutes 'compliance,' which could lead to inconsistent interpretations or implementations by various parties involved, potentially affecting transparency and accountability. This issue is in Section 2(b).
The language requiring 'specific statutory authority... with express reference to this Act' could be considered overly precise and potentially lead to legal challenges or difficulty in interpretation, affecting the enforceability of the Act. This is another issue identified in Section 2(a).
The provision mentions compliance certification to multiple committees, which might lead to redundant reporting or administrative burdens for the Secretary of Health and Human Services and NIH. This issue is identified in Section 2(b).
Sections
Sections are presented as they are annotated in the original legislative text. Any missing headers, numbers, or non-consecutive order is due to the original text.
1. Short title Read Opens in new tab
Summary AI
The first section of this Act states its short title, which is the “Protecting Medical Research Funding Act.”
2. Limitation on deferral or transfer of Federal funds made available for NIH Read Opens in new tab
Summary AI
The section limits how the government can manage funds given to the National Institutes of Health (NIH). It states that these funds cannot be held back, moved, or re-used in a different way unless a new law is passed to allow it. Additionally, the Secretary of Health and Human Services must prove every year that they are following this rule.